Managing comorbid disease in patients with psoriatic arthritis

被引：26

作者：

Husni M.E. ^{[1
]}

Mease P.J. ^{[2
]}

机构：

[1] Cleveland Clinic, Orthopedic and Rheumatologic Institute, Cleveland, OH 44195

[2] Division of Rheumatology Research, Swedish Medical Center, University of Washington School of Medicine, Seattle, WA

来源：

Current Rheumatology Reports | 2010年 / 12卷 / 4期

关键词：

Cardiovascular disease; Comorbidities; Depression; Infection; Malignancy; Obesity; Osteoporosis; Psoriasis; Psoriatic arthritis;

D O I：

10.1007/s11926-010-0112-3

中图分类号：

学科分类号：

摘要：

Psoriatic arthritis (PsA) is a unique type of inflammatory arthritis that is associated with skin psoriasis. The concept that PsA is simply a skin and joint disease has been challenged by large epidemiologic studies that link PsA with substantial comorbidity. Important comorbidities related to PsA include premature cardiovascular disease, infectious complications, malignancy risk, osteoporosis, and reduced quality of life. This review focuses on the prevalent comorbid diseases in patients with PsA and highlights how the presence of these associated comorbidities can affect the management of these patients. © 2010 Springer Science+Business Media, LLC.

引用

页码：281 / 287

页数：6

共 37 条

[1]

Eder L., Zisman D., Barzilai M., Et al., Subclinical atherosclerosis in psoriatic arthritis: A case-control study, J Rheumatol, 35, pp. 877-882, (2008)

[2]

Tam L.S., Tomlinson B., Chu T.T., Et al., Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation, Rheumatology (Oxford), 47, pp. 718-723, (2008)

[3]

Ciocon D.H., Horn E.J., Kimball A.B., Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: Results of the 2005 spring US National Psoriasis Foundation survey, Am J Clin Dermatol, 9, pp. 111-117, (2008)

[4]

Gelfand J.M., Neimann A.L., Shin D.B., Et al., Risk of myocardial infarction in patients with psoriasis, JAMA, 296, pp. 1735-1741, (2006)

[5]

Gladman D.D., Mortality in psoriatic arthritis, Clin Exp Rheumatol, 26, 5 SUPPL. 51, (2008)

[6]

Kimball A.B., Jacobson C., Weiss S., Et al., The psychosocial burden of psoriasis, Am J Clin Dermatol, 6, pp. 383-392, (2005)

[7]

Gottlieb A.B., Dann F., Comorbidities in patients with psoriasis, Am J Med, 122, (2009)

[8]

Laas K., Roine R., Rasanen P., Et al., HUS QoL Study Group: Health-related quality of life in patients with common rheumatic diseases referred to a university clinic, Rheumatol Int, 29, pp. 267-273, (2009)

[9]

Mease P.J., Menter M.A., Quality-of-life issues in psoriasis and psoriatic arthritis: Outcome measures and therapies from a dermatological perspective, J Am Acad Dermatol, 54, pp. 685-704, (2006)

[10]

Naldi L., Chatenoud L., Linder D., Et al., Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study, J Invest Dermatol, 125, pp. 61-67, (2005)

← 1 2 3 4 →